博客

其他健康状况

Fasenra: An Effective Solution for Eosinophilic Asthma

Asthma patient on Fasenra

Fasenra is an injectable prescription drug with the active substance, benralizumab. It is approved for treating eosinophilic asthma in adolescents (children aged 12 years or over) and adults. In people whose asthma is not controlled by their existing asthma drugs, Fasenra is used as an add-on therapy.

与专家交谈

关于共付额援助
(877) 778-0318

It is frequently used with other asthma medications (inhaled corticosteroids) to treat asthma symptoms, including wheezing and shortness of breath, and to avoid asthma episodes (flare-ups).

Fasenra can only be obtained via doctor’s prescription and is available in solution form for injection purposes. 

Is There a Generic for Fasenra?

There is no biosimilar (generic) of Fasenra. It is only available in brand form, making the medication expensive, even with insurance. 

What Is It Used To Treat?

Fasenra has only been approved to treat eosinophilic asthma; it has not been approved to treat other eosinophil-related illnesses or severe acute asthma, such as acute bronchospasm or status asthmaticus.

Patients with eosinophilic asthma (EA), an uncommon but severe form of asthma, frequently have a disproportionately high quantity of eosinophils in their blood and phlegm (thick mucus) in their lungs. Eosinophils are the kind of white blood cell that ordinarily fights off infection-causing germs.

In the case of eosinophilic asthma (EA), however, the activation of too many eosinophils by typical asthma triggers produces inflammation and swelling in the respiratory tract, resulting in difficulty breathing and asthma attacks.

How Does Fasenra Work?

Fasenra works to reduce the number of eosinophils and improve asthma symptoms. The active component, benralizumab, is a monoclonal antibody (IgG1) and is designed to attach to the surface receptors (interleukin-5 receptors) of eosinophils. Fasenra activates the natural body’s defense mechanism (immune system) after attaching to the surface receptors. 

Once activated, the immune system destroys eosinophils in the blood and lungs. As a result, the number of eosinophils and inflammation are reduced, and symptoms are improved.

How Long Does It Take To Work?

Fasenra works within 24 hours. A significant reduction of eosinophil levels in the blood was observed in patients after taking the medication. Moreover, the symptoms of asthma exacerbation started to reduce and lung functions improved after 4 weeks of Fasenra treatment. 

However, if a patient has severe eosinophilic asthma, they will require treatment for some time until they show improvement in their condition. 

Dosage Form and Strength

Fasenra comes in one strength: 30 mg/ml of a colorless liquid solution. It is available in two forms:

  • Single-dose, prefilled syringes designed for healthcare professionals
  • Single-dose, prefilled autoinjector pens designed for patients or caregivers

Each single-dose prefilled syringe delivers 1 ml containing 30 mg of benralizumab into the body. 

剂量信息

The recommended dose of Fasenra for adults and children 12 years or older is 30 mg/ml once every 4 weeks for the first three doses and then once every 8 weeks thereafter. 

治疗信息

Get Fasenera Prior Authorization
安排咨询

How Is Fasenra Given?

The 30 mg/ml dose of Fasenra is injected under the skin beneath the fat layer (subcutaneous). 

The prefilled injection is usually given by a healthcare provider under the skin of the upper arms, thighs, and abdomen (belly) areas. 

After proper training, patients and their caregivers can inject Fasenra injection. 

Proper Method of Administration

Fasenra should be administered by a healthcare provider. However, if you or your caregiver received sufficient training, be sure to inject the medication as directed by a healthcare expert.

Before administering Fasenra, leave the medication at room temperature for 30 minutes. 

  • Gently remove the needle cover and sanitize the injection sites (i.e., abdomen, thighs, or upper arms) with alcohol pads. 
  • Pinch the skin of the injection site and inject all the medication slowly by pushing the syringe plunger downward. 
  • After injection, slowly remove the needle from the skin and discard it in the sharps container. 

Is Fasenra a Form of Chemotherapy?

Fasenra is not a chemotherapeutic agent, but rather a prescription medication used to treat eosinophilic asthma in adults and children aged 12 and above.

Possible Side Effects of Fasenra

Fasenra patient with fever

Fasenra has some common and severe side effects, like other medications. The most common mild side effects that 1 in 10 patients experience are:

  • Sore throat (pharyngitis)
  • 头痛
  • 发烧
  • Injection site reaction

These minor side effects are generally transitory and disappear after a few days of therapy. However, if these symptoms persist despite medication, visit your healthcare physician.

严重的副作用

Fasenra also has some serious adverse effects; however, they are uncommon. These include:

Allergic (Hypersensitivity) Reactions 

According to clinical studies, only 3% of patients who took Fasenra showed allergic reactions. The symptoms of an allergic reaction include:

  • Hives or rashes 
  • Facial, mouth, and throat swelling
  • Feeling lightheaded or dizzy, and fainting due to low blood pressure
  • Breathing problems

与专家交谈

(877) 778-0318

防范措施

If you have certain medical conditions, Fasenra may not be suitable for you. Therefore, it is recommended to consult your healthcare provider in the following cases: 

  • If you are pregnant or intend to become pregnant, avoid taking Fasenra injections since the impact of Fasenra on the fetus has not been studied yet.
  • If you are breastfeeding or planning to breastfeed, it is recommended not to breastfeed while receiving Fasenra injections since the data on Fasenra secretion in human breast milk is limited
  • If you have an allergy to any component of Fasenra, do not take this medication.
  • If you have a parasitic (helminth) infection, avoid taking Fasenra, as it may worsen the infection. In other cases, if a patient becomes infected with a parasitic infection, it is recommended to discontinue administration immediately. 
  • If you have acute bronchospasm or status asthmaticus (severe asthma), avoid taking Fasenra, as it is not recommended to treat acute asthma symptoms or acute exacerbations.
  • If you are taking multivitamins, herbal supplements, or over-the-counter medicines, inform your doctor. 
  • If you are taking oral or other inhaled corticosteroid prescriptions, use Fasenra as advised by your doctor.

Fasenra Cost 

The cost of Fasenra subcutaneous solution (30 mg/ml strength) in a prefilled syringe and autoinjector pens is about $5,197. However, the cost of this medication depends on many factors, including the pharmacy you visit. 

参考:

  1. US Food and Drug Administration (FDA). Fasenra Prescribing information. https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/761070s000lbl.pdf
  2. European Medical Agency (EMC). Fasenra Prescribing information. https://www.ema.europa.eu/en/documents/product-information/fasenra-epar-product-information_en.pdf
  3. Bakakos, Loukides, & Bakakos. (2019). Severe Eosinophilic Asthma. 临床医学杂志, 8(9), 1375. https://doi.org/10.3390/jcm8091375
  4. de Groot, J. C., ten Brinke, A., & Bel, E. H. (2015). Management of the patient with eosinophilic asthma: a new era begins. ERJ Open Research, 1(1), 00024–02015. https://doi.org/10.1183/23120541.00024-2015
此信息不能替代医疗建议或治疗。在开始任何新的治疗之前,请咨询您的医生或医疗保健提供者,了解您的医疗状况。AmeriPharma® Specialty Care 对所提供的信息或由此做出的任何诊断或治疗不承担任何责任,也不对其内容的可靠性负责。AmeriPharma® Specialty Care 并非运营此处列出的所有网站/组织,也不对其内容的可用性或可靠性负责。这些列表并不暗示或构成 AmeriPharma® Specialty Care 的认可、赞助或推荐。本网页可能包含对品牌处方药的引用,这些处方药是与 AmeriPharma® Specialty Care 无关的制药商的商标或注册商标。
医学审核人 Martina Mikail 博士,药学博士

Martina Mikail 博士(药学博士)出生于埃及,在宾夕法尼亚州和加利福尼亚州长大。她于2022年5月毕业于马歇尔·B·凯彻姆大学。Mikail 博士曾荣获美国邮政署(USPS)领导力奖和美国医疗保健协会(CSHP)领导力奖,并且是 CSHP、ASHP 和 APhA 的活跃成员。她工作中最有成就感的部分是为患者提供用药教育和咨询。闲暇时,她喜欢烹饪、陪伴家人和阅读。

联系我们

使用下方符合 HIPAA 标准的表格申请续药。如果您对药物或用药方法有任何疑问,请访问“联系我们”页面或致电 (877) 778-0318.

HIPAA Compliant

提交即表示您同意 AmeriPharma 的 使用条款, 隐私政策, 和 隐私惯例通知

zh_CNChinese